" /> " />

CryoCell International Earnings Estimate

CCEL Stock  USD 8.55  0.10  1.18%   
The next projected EPS of CryoCell International is estimated to be 0.04 with future projections ranging from a low of 0.04 to a high of 0.04. CryoCell International's most recent 12-month trailing earnings per share (EPS TTM) is at -1.16. Please be aware that the consensus of earnings estimates for CryoCell International is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
CryoCell International is projected to generate 0.04 in earnings per share on the 31st of May 2024. CryoCell International earnings estimates module stress-tests analyst consensus about projected CryoCell International EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as CryoCell International, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing CryoCell International's earnings estimates, investors can diagnose different trends across CryoCell International's analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is expected to rise to about 27.7 M this year, although the value of Pretax Profit Margin is projected to rise to (0.36).
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.

CryoCell International Earnings Estimation Breakdown

The calculation of CryoCell International's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of CryoCell International is estimated to be 0.04 with the future projection ranging from a low of 0.04 to a high of 0.04. Please be aware that this consensus of annual earnings estimates for CryoCell International is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.07
0.04
Lowest
Expected EPS
0.04
0.04
Highest

CryoCell International Earnings Projection Consensus

Suppose the current estimates of CryoCell International's value are higher than the current market price of the CryoCell International stock. In this case, investors may conclude that CryoCell International is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and CryoCell International's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of May 2024Current EPS (TTM)
0-32.78%
0.07
0.04
-1.16

CryoCell International Earnings per Share Projection vs Actual

Actual Earning per Share of CryoCell International refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering CryoCell International predict the company's earnings will be in the future. The higher the earnings per share of CryoCell International, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

CryoCell International Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as CryoCell International, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of CryoCell International should always be considered in relation to other companies to make a more educated investment decision.

CryoCell Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact CryoCell International's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-04-15
2024-02-29-0.020.070.09450 
2024-02-28
2023-11-30-0.07-1.34-1.271814 
2023-10-12
2023-08-31-0.060.080.14233 
2023-07-14
2023-05-31-0.080.030.11137 
2023-04-21
2023-02-28-0.040.090.13325 
2023-02-28
2022-11-30-0.020.10.12600 
2019-02-28
2018-11-3000.130.13
2018-02-28
2017-11-3000.480.48
2017-02-28
2016-11-3000.070.07
2016-02-29
2015-11-300-0.0137-0.0137
2015-02-28
2014-11-3000.02910.0291
2014-02-28
2013-11-3000.03710.0371
2011-02-28
2010-11-3000.01990.0199
2007-02-28
2006-11-300.03-0.08-0.11366 
2006-10-16
2006-08-310.03-0.09-0.12400 

About CryoCell International Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of CryoCell International earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current CryoCell International estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as CryoCell International fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-28 M-29.4 M
Retained Earnings Total Equity-21.6 M-22.7 M
Earnings Yield(0.19)(0.18)
Price Earnings Ratio(4.22)(4.01)
Price Earnings To Growth Ratio 0.01  0.01 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CryoCell International in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CryoCell International's short interest history, or implied volatility extrapolated from CryoCell International options trading.

Pair Trading with CryoCell International

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CryoCell International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CryoCell International will appreciate offsetting losses from the drop in the long position's value.

Moving against CryoCell Stock

  0.84ETON Eton Pharmaceuticals Upward RallyPairCorr
  0.78EGRX Eagle PharmaceuticalsPairCorr
  0.78EVOK Evoke PharmaPairCorr
  0.78EXAI Exscientia ADR Financial Report 22nd of May 2024 PairCorr
  0.71TFX Teleflex Incorporated Earnings Call This WeekPairCorr
The ability to find closely correlated positions to CryoCell International could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CryoCell International when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CryoCell International - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CryoCell International to buy it.
The correlation of CryoCell International is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CryoCell International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CryoCell International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CryoCell International can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether CryoCell International is a strong investment it is important to analyze CryoCell International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CryoCell International's future performance. For an informed investment choice regarding CryoCell Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.
Note that the CryoCell International information on this page should be used as a complementary analysis to other CryoCell International's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for CryoCell Stock analysis

When running CryoCell International's price analysis, check to measure CryoCell International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CryoCell International is operating at the current time. Most of CryoCell International's value examination focuses on studying past and present price action to predict the probability of CryoCell International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CryoCell International's price. Additionally, you may evaluate how the addition of CryoCell International to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stocks Directory
Find actively traded stocks across global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Is CryoCell International's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.25)
Earnings Share
(1.16)
Revenue Per Share
3.783
Quarterly Revenue Growth
0.004
Return On Assets
(0.01)
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.